Tumor-size-based morphological features of metastatic lymph node tumors from primary lung adenocarcinoma

Pathology International

Volumn 64, Issue 12, 2014, Pages 591-600

  Yamada, Eiji ^a   Ishii, Genichiro ^a   Aramaki, Nao ^a   Aokage, Keiju ^a   Hishida, Tomoyuki ^a   Yoshida, Junji ^a   Kojima, Motohiro ^a   Nagai, Kanji ^a   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Diversity; Lung adenocarcinoma; Lymph node metastasis; Micrometastasis

Indexed keywords

ADENOCARCINOMA; AGED; FEMALE; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; SECONDARY;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED;

EID: 84912523937     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12213     Document Type: Article

References (33)

1. Travis WD, Brambilla E, Noguchi M etal. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
2. Lee HJ, Kim YT, Kang CH etal. Epidermal growth factor receptor mutation in lung adenocarcinomas: Relationship with CT characteristics and histologic subtypes. Radiology 2013; 268: 254-264.
3. Takuwa T, Ishii G, Nagai K etal. Characteristic immunophenotype of solid subtype component in lung adenocarcinoma. Ann Surg Oncol 2012; 19: 3943-3952.
4. Russell PA, Wainer Z, Wright GM etal. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 2011; 6: 1496-1504.
5. Kim H, Yoo SB, Sun P etal. Alteration of the E-Cadherin/beta-catenin complex is an independent poor prognostic factor in lung adenocarcinoma. Korean J Pathol 2013; 47: 44-51.
6. Zhang Y, Sun Y, Pan Y etal. Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis. Clin Cancer Res 2012; 18: 1947-1953.
7. Gao D, Nolan DJ, Mellick AS etal. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008; 319: 195-198.
8. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
9. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
10. Ksiazkiewicz M, Markiewicz A, Zaczek AJ. Epithelial-mesenchymal transition: A hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology 2012; 79: 195-208.
11. Brabletz T, Jung A, Reu S etal. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001; 98: 10356-10361.
12. Aokage K, Ishii G, Yoshida J etal. Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma. Pathol Int 2010; 60: 765-773.
13. International Union against Cancer, Sobin LH, Gospodrowicz MK, Wittekind CH, eds. TNM Classification of Malignant Tumours, 7th edn. New York: Wiley-Liss, 2009.
14. Yeung TM, Buskens C, Wang LM etal. Myofibroblast activation in colorectal cancer lymph node metastases. Br J Cancer 2013; 108: 2106-2115.
15. Yanagita S, Natsugoe S, Uenosono Y etal. Sentinel node micrometastases have high proliferative potential in gastric cancer. J Surg Res 2008; 145: 238-243.
16. Yokoyama H, Nakanishi H, Kodera Y etal. Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line. Clin Cancer Res 2006; 12: 361-368.
17. Sica G, Yoshizawa A, Sima CS etal. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 2010; 34: 1155-1162.
18. Chao YL, Shepard CR, Wells A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 2010; 9: 179.
19. Klymkowsky MW, Savagner P. Epithelial-mesenchymal transition: A cancer researcher's conceptual friend and foe. Am J Pathol 2009; 174: 1588-1593.
20. Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: Unique cadherin profiles in tumor progression. Clin Exp Metastasis 2008; 25: 643-655.
21. Hugo H, Ackland ML, Blick T etal. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213: 374-383.
22. Chaffer CL, Thompson EW, Williams ED. Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 2007; 185: 7-19.
23. Chaffer CL, Brennan JP, Slavin JL etal. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2. Cancer Res 2006; 66: 11271-11278.
24. Tsai JH, Donaher JL, Murphy DA etal. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012; 22: 725-736.
25. Aokage K, Ishii G, Ohtaki Y etal. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. Int J Cancer 2011; 128: 1585-1595.
26. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-768.
27. Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 2008; 26: 2813-2820.
28. Morel AP, Lievre M, Thomas C etal. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008; 3: e2888.
29. Mani SA, Guo W, Liao MJ etal. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
30. Hermann PC, Huber SL, Herrler T etal. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-323.
31. Rusch VW, Hawes D, Decker PA etal. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: Report of the ACOSOG Z0040 trial. J Clin Oncol 2011; 29: 4313-4319.
32. de Boer M, van Deurzen CH, van Dijck JA etal. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009; 361: 653-663.
33. Yasumoto K, Osaki T, Watanabe Y etal. Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: A multicenter prospective study. Ann Thorac Surg 2003; 76: 194-201.